AI-ACCELERATED DRUG DISCOVERY

Focused On-demand Library for Catenin alpha-2

Available from Reaxense
Predicted by Alphafold

Focused On-demand Libraries - Reaxense Collaboration

Explore the Potential with AI-Driven Innovation

The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.

The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.

The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.

Our high-tech, dedicated method is applied to construct targeted libraries.

 Fig. 1. The sreening workflow of Receptor.AI

By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.

Our library is unique due to several crucial aspects:

  • Receptor.AI compiles all relevant data on the target protein, such as past experimental results, literature findings, known ligands, and structural data, thereby enhancing the likelihood of focusing on the most significant compounds.
  • By utilizing advanced molecular simulations, the platform is adept at locating potential binding sites, rendering the compounds in the focused library well-suited for unearthing allosteric inhibitors and binders for hidden pockets.
  • The platform is supported by more than 50 highly specialized AI models, all of which have been rigorously tested and validated in diverse drug discovery and research programs. Its design emphasizes efficiency, reliability, and accuracy, crucial for producing focused libraries.
  • Receptor.AI extends beyond just creating focused libraries; it offers a complete spectrum of services and solutions during the preclinical drug discovery phase, with a success-dependent pricing strategy that reduces risk and fosters shared success in the project.

partner

Reaxense

upacc

P26232

UPID:

CTNA2_HUMAN

Alternative names:

Alpha N-catenin; Alpha-catenin-related protein

Alternative UPACC:

P26232; B3KXE5; B7Z2W7; B7Z352; B7Z898; Q4ZFW1; Q53R26; Q53R33; Q53T67; Q53T71; Q53TM8; Q7Z3L1; Q7Z3Y0

Background:

Catenin alpha-2, also known as Alpha N-catenin and Alpha-catenin-related protein, plays a pivotal role in the nervous system's cell-cell adhesion and differentiation. It is essential for cortical neuronal migration and neurite growth, acting as a negative regulator of the Arp2/3 complex and actin polymerization. This regulation is crucial for maintaining neurite growth and stability by suppressing excessive actin branching. Additionally, Catenin alpha-2 is involved in synaptic morphological plasticity and the lamination of the cerebellar and hippocampal regions during development.

Therapeutic significance:

Catenin alpha-2's mutation is linked to Cortical dysplasia, complex, with other brain malformations 9, a severe neurodevelopmental disorder. Understanding the role of Catenin alpha-2 could open doors to potential therapeutic strategies for this and related neurological conditions.

Looking for more information on this library or underlying technology? Fill out the form below and we'll be in touch with all the details you need.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No Spam. Cancel Anytime.